Maternal antibodies that do not provide significant immunity in a neonate?

Explanation

## Correct Answer: C. Polio Poliovirus immunity depends critically on **mucosal IgA antibodies** in the intestinal tract, which are the primary defense against infection at the site of viral replication. Maternal IgG antibodies, while present in neonates, do not provide adequate mucosal immunity because IgG does not cross the intestinal epithelium effectively and maternal IgA is not transferred to the infant. This is the fundamental discriminator: polio requires local mucosal immunity, not systemic immunity. In contrast, tetanus, measles, and diphtheria are toxin-mediated or systemic diseases where maternal IgG provides significant passive protection. Maternal anti-poliovirus IgG may offer transient serum neutralizing activity, but this is insufficient to prevent infection at the intestinal mucosa where the virus replicates. This is why oral polio vaccine (OPV) is given from birth in India's Universal Immunization Programme—maternal antibodies do not reliably protect against natural infection or prevent vaccine virus replication. The neonate remains vulnerable to wild-type poliovirus exposure despite maternal seropositivity, making polio unique among these vaccine-preventable diseases in terms of lack of maternal protection. ## Why the other options are wrong **A. Tetanus** — Tetanus is a **toxin-mediated disease** where maternal anti-tetanus toxoid IgG antibodies provide excellent passive immunity lasting 3–4 months. These antibodies neutralize tetanus toxin in the bloodstream, preventing clinical disease. Neonatal tetanus is prevented by maternal immunization during pregnancy (part of Indian antenatal care guidelines). This is why tetanus is NOT the answer—maternal antibodies ARE protective. **B. Measles** — Maternal anti-measles IgG provides **significant passive immunity** for approximately 6–9 months, protecting the neonate from measles infection. This is why measles vaccination is delayed until 9–12 months in India's schedule—maternal antibodies would neutralize the vaccine virus. Maternal antibodies are highly protective against measles, making this option incorrect. **D. Diphtheria** — Diphtheria is caused by **diphtheria toxin**, and maternal anti-diphtheria toxoid IgG antibodies effectively neutralize this toxin, providing passive protection for 3–4 months. Maternal immunization during pregnancy ensures adequate transplacental transfer of protective antibodies. Like tetanus, diphtheria protection is toxin-based and maternal antibodies ARE protective, so this is not the correct answer. ## High-Yield Facts - **Polio immunity** requires **mucosal IgA**, not systemic IgG—maternal IgG does not protect against intestinal infection. - **Tetanus and diphtheria** are toxin-mediated; maternal IgG neutralizes toxins and provides 3–4 months of passive protection. - **Measles** maternal IgG provides 6–9 months of passive immunity; vaccination is delayed until 9–12 months to avoid antibody interference. - **OPV (oral polio vaccine)** is given from birth in India because maternal antibodies do not prevent intestinal replication or vaccine take. - **Mucosal immunity** (IgA) is NOT transferred transplacentally; only **systemic IgG** crosses the placenta. ## Mnemonics **MUCOSAL = Maternal Antibodies Useless** Polio is a **mucosal disease** (intestinal replication) → maternal IgG (systemic) cannot protect → no significant immunity. Tetanus, diphtheria, measles are systemic/toxin-mediated → maternal IgG works. **TDM = Toxin/Systemic Diseases get Maternal protection** **T**etanus (toxin), **D**iphtheria (toxin), **M**easles (systemic viremia) all protected by maternal IgG. **P**olio (mucosal) is NOT. ## NBE Trap NBE pairs polio with other vaccine-preventable diseases to test whether students conflate "vaccine-preventable" with "protected by maternal antibodies." The trap is assuming all IgG-mediated immunity is equally protective; students must recognize that **mucosal diseases require mucosal immunity**, which maternal antibodies cannot provide. ## Clinical Pearl In India, even in mothers with high anti-poliovirus titers, neonates can acquire polio from wild-type virus or vaccine virus (in rare cases of immunodeficiency contacts). This is why India's RNTCP emphasizes OPV from birth—maternal serology is irrelevant for mucosal protection. A neonate born to a fully immunized mother can still develop polio if exposed to the virus in the community. _Reference: OP Ghai Pediatrics Ch. 5 (Immunization); Harrison Ch. 196 (Poliovirus); Robbins Ch. 8 (Viral Infections)_